Stada appoints Goldschmidt as permanent CEO

1 February 2018 - Deborah Wilkes


Stada Arzneimittel has appointed Peter Goldschmidt – a senior executive at Novartis' Sandoz division – as its new permanent chief executive officer. He will be the German generics and OTC company's fifth chief executive officer in around two years.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: